Laatste nieuws in biotech
Dutch Avian Flu Vaccination Mandate Set to Boost Regional Veterinary Markets
The Hague, Friday 15 May 2026
Following the culling of over two million birds, the newly announced Dutch mandate for avian flu vaccinations creates significant commercial opportunities for the regional veterinary pharmaceutical sector.
Historic Ten-Cent Drug Slashes Heart Failure Hospitalisations by a Quarter
Groningen, Tuesday 12 May 2026
Dutch researchers have revealed that digoxin, an ancient medication costing under €0.10 daily, reduces heart failure hospitalisations by 25%, potentially transforming future cardiovascular treatment guidelines and healthcare economics.
Jaguar Health Pursues Expedited FDA Approval for Rare Paediatric Disease Treatment
Amsterdam, Thursday 7 May 2026
Jaguar Health is advancing FDA talks for crofelemer, a novel therapy already reducing life-sustaining support needs for 4% of children living with an ultrarare, previously untreatable intestinal disorder.
BioMarin's Voxzogo Drives Significant Long-Term Growth in Children with Achondroplasia
San Rafael, Saturday 2 May 2026
New 2026 clinical data reveals children treated with BioMarin’s Voxzogo achieved an impressive height increase of 13.59 cm over eight years, maintaining proportional skeletal growth and bone health.
Moolec Science Reaches Commercial Scale in Plant-Based Bioengineering for Sustainable Markets
Luxembourg City, Wednesday 29 April 2026
Following a record harvest, Moolec Science has industrialised its safflower bioengineering platform. Achieving a remarkable 45% concentration at commercial scale, the firm targets sustainable renewable energy markets.